Abstract
Small molecules with selective efficacy can be used as drugs. Drugs typically have a therapeutic dose range where the benefit from intended effects outweighs the cost of unintended (side) effects. Herein, I use case scenarios to illustrate potential advantages and pitfalls of treatment with drugs alone or in combination. Combinations of drugs may show surprising effects given the effects of individual drugs, in phenomena known as drug interactions. Drug interactions can be classified as synergistic or antagonistic, if the effect of the combination is higher or lower than expected, respectively. A better understanding of drug interactions and their relationship to phenotypes offers hope in finding drug combinations that have high therapeutic values.
Keywords: Antibiotic resistance, dose-response curves, drug combinations, drug interactions, drug synergy, pharmacology, selective efficacy, therapeutic window
Current Drug Discovery Technologies
Title:Drugs and their Interactions
Volume: 10 Issue: 2
Author(s): Murat Cokol
Affiliation:
Keywords: Antibiotic resistance, dose-response curves, drug combinations, drug interactions, drug synergy, pharmacology, selective efficacy, therapeutic window
Abstract: Small molecules with selective efficacy can be used as drugs. Drugs typically have a therapeutic dose range where the benefit from intended effects outweighs the cost of unintended (side) effects. Herein, I use case scenarios to illustrate potential advantages and pitfalls of treatment with drugs alone or in combination. Combinations of drugs may show surprising effects given the effects of individual drugs, in phenomena known as drug interactions. Drug interactions can be classified as synergistic or antagonistic, if the effect of the combination is higher or lower than expected, respectively. A better understanding of drug interactions and their relationship to phenotypes offers hope in finding drug combinations that have high therapeutic values.
Export Options
About this article
Cite this article as:
Cokol Murat, Drugs and their Interactions, Current Drug Discovery Technologies 2013; 10 (2) . https://dx.doi.org/10.2174/1570163811310020003
DOI https://dx.doi.org/10.2174/1570163811310020003 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases
Mini-Reviews in Medicinal Chemistry Modulation of Regulatory T Cells in Health and Disease: Role of Toll-Like Receptors
Inflammation & Allergy - Drug Targets (Discontinued) Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces
Current Medicinal Chemistry Farnesyltransferase Inhibitors: A Detailed Chemical View on an Elusive Biological Problem
Current Medicinal Chemistry Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma
Current Gene Therapy Gist Representations and Communication of Risks about HIV-AIDS: A Fuzzy-Trace Theory Approach
Current HIV Research AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Synthesis and Cytotoxic Evaluation of Novel Symmetrical Taspine Derivatives as Anticancer Agents
Medicinal Chemistry Hormone Responsive Breast Cancer and BRCA1 Mutation: Mechanism, Regulation and Iron-mediated Effects
Current Pharmaceutical Biotechnology The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry 4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies
Anti-Cancer Agents in Medicinal Chemistry Drug-Induced Hair Disorders
Current Drug Safety Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Chalcones in Cancer: Understanding their Role in Terms of QSAR. II Part
Mini-Reviews in Medicinal Chemistry Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy
Current Drug Metabolism